Tel 0571 568 147
Fax 0571 568 132

vb@vincibiochem.it
LogoVB 

 

Marker Gene Technologies, Inc
MGT is a primary manufacturer. Order from the source! Kits for Marker Genes Detection, Fluorescent Reagents, Labelling Reagents & Cell Regulatory Substrates.

 

Removal of Marker Genes.

Marker genes find numerous applications in animal and plant systems, but can also cause consumer concern when used in commercial products or add regulatory requirements from the presence of "excess" exogenous DNA.  Several methods have recently been introduced to remove marker genes in plants, using site-specific recombination systems (e.g., lox/Cre recombinase, Flp recombination target (FRT)/Flp recombinase, or Rs/R recombinase) and by using an inducible promoter system (e.g. for b-estradiol) for the recombinase gene.  In these recombination schemes, the marker gene is flanked by recombination sites, such as lox, FRT, or Rs, which specifically interact with a recombinase protein (e.g., Cre, Flp, or R, respectively).  This interaction promotes recombination between the sites and deletes the marker DNA from the host genome.  For more information about these techniques see the references below.

  • David W. Ow The right chemistry for Marker Gene removal? (2001) Nature Biotechnol. 19(2): 115  116.

  • Zuo, J., Niu, Q.-W., Moller, S.G. & Chua, N.-H. Chemical-regulated, site-specific DNA excision in transgenic plants. Nat. Biotechnol. 19, 157-161 (2001).

  • Sugita, K., Kasahara, T., Matsunaga, E. & Ebinuma. H. A transformation vector for the production of marker-free transgenic plants containing a single copy transgene at high frequency Plant J. 22, 461-469 (2000). 

 

Small Molecule Activator of Caspase-3.

Professor Xiaodong Wang, and co-workers at the Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX have identified a small molecule activator of apoptosis, alpha -(trichloromethyl)-4-pyridineethanol (PETCM), using high-throughput screening in a panel of cancer cells in culture.  PETCM was found to be a selective activator of caspase-3.  Caspase-3 is an important member of the family of enzymes implicated in the initial events of programmed cell death.  The identification of these types of active compounds, point the way toward understanding the death initiator processes in tumor cells (two proteins were implicated in the present study), and may lead to new types of chemotherapies for intractable cancers.  For more information about this work, see the references below.

  • Distinctive Roles of PHAP Proteins and Prothymosin-a in a Death Regulatory Pathway, X. Jiang, H.E. Kim, H. Shu, Y. Zhao, H. Zhang, J. Kofron, J. Donnelly, D. Burns, S.C. Ng, S. Rosenberg, X. Wang, Science 299 (2003) 223-226.

  • Apoptosis: Life and Death Decisions D.W. Nicholson and N.A. Thornberry, Science 299 (2003) 214-215.

 

Quantum Dot Fluorescence Applications.

Quantum dots (Qdots) are polymer-coated beads that contain nanometer scale microcrystals of semiconductor material (cadmium selenide).  Arising from the solar energy research (photovoltaic cell conversion studies) of the 1980s, they can be excited at a wide range of wavelengths (300-500nm) and produce bright fluorescence emission, with the color dependent upon the size of the contained nanocrystals.  In addition, they are much more photostable than typical fluorescent dyes.  Many quantum-dot bio-conjugates have been prepared and used in cell labeling studies, and even intracellularly, with uptake by endocytosis.  For more information, see the references below.

  • Rosenthal, S.J., Tomlinson, I., Adkins, E.M., Schroeter, S., Adams, S., Swafford, L., McBride, J., Wang, Y., DeFelice, I.J., Blakely, R.D., Targeting Cell Surface Receptors with Ligand Conjugated Nanocrystals. J. Am. Chem. Soc. 124(17):4586-4594 (2002).

  • kerman, M.E., Chan, W.C., Laakkonen, P., Bhatia, S.N., Ruoslahti, E., Nanocrystal Targeting In Vivo. Proc. Natl Acad. Sci. USA 99:12617-12621 (2002).

  • Watson, A., Xingyong, W., Bruchez, M., Lighting Up Cells with Quantum Dots. (2003) Biotechniques 34(2): 296-303.

Stems Cells found Totipotent by lacZ Staining.

Dr. Diana Clark and colleagues at the Medical Nobel Institute in Stockholm, Sweden traced the differentiation of neural stem cells by lacZ transfection and staining.  They found these cells could be induced to differentiate into most of the cells of the body.  This work is promising for use of stem cells to potentially re-populate damaged tissue after stroke or spinal cord injury or aide in regenerating tissues in multiple sclerosis, diabetes or neurodegenerative diseases.  For more information about these studies, see the references below.  Marker Gene sells several products for sensitive and specific staining of lacZ-positive cells and tissues (including: M0250; M0259; M0241; M0255; and M0257).

  • Clarke, D. L. Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U, Frisen J., Generalized potential of adult neural stem cells. Science 288, 1660-1663 (2000).

  • McKay, R., Mammalian deconstruction for stem cell reconstruction Nature Medicine (2000) 6( 7):747-748.

 

a- Galactosidase Marker Gene for Yeast.

 

The yeast two-hybrid screen is a genetic method of detecting protein-protein interactions in vivo.  Positive clones are selected by their ability to activate the transcription of a reporter gene, which also enables them to grow on nutritionally selective media.  Most two-hybrid methods use the E. coli lacZ gene as the reporter gene.  Usually the colonies growing on the selection plates are assayed for the activation of the reporter gene lacZ by a filter-lift assay.  Marker Gene currently produces several substrates that are useful for b-Gal detection in yeast strains (M0250, FDG; M0203, Resorufin-Gal; M0252, TFMU-Gal, M0257, CUG).   Recently yeast strains producing the a-galactosidase marker gene have been developed and used to assay GAL4-based two-hybrid interactions directly on nutritional selection plates with the chromogenic substrate X-a-Gal.  Look for new products from Marker Gene in this area in the near future.  For more information about these techniques, see the references below.

 

  • S. Aho, A. Arffman, T.Pummi and J. Uitto, A novel reporter gene MEL1 for the yeast two-hybrid system. Anal. Biochem., 253, 270-272  (1997).

  • P. Chevalier, D. Roy and and L. Savoie, X-a-gal-based medium for simultaneous enumeration of bifidobacteria and lactic acid bacteria in milk., J.Microbiol. Meth., 13, 75 (1991).

  • R. Gossrau and Z. Lojda, Histochemical detection of a-D-galactosidase with 5-Br-4-Cl-3-indoxyl a-D-galactoside. Acta Histochem., 85, 213 (1989).

  • R.S. Tubb and P.L. Liljestrom, A colony-colour method which differentiates a-galactosidase positive strains of yeast. J. Inst. Brew. 92, 588, (1986).

 

Toward a Marker Gene for Colorectal Tumors.

The long-standing hope of finding specific reporter genes that are upregulated in tumors has recently shown renewed promise in work published by Dr. Andrew Feinberg and his group at Johns Hopkins University School of Medicine.  By examining the DNA methylation patterns of patients with genetic predisposition to colorectal cancer or who have been diagnosed with the disease, they found statistically higher levels of gene silencing in the gene IGF2 (insulin-like growth factor 2) in these patients (5X or 21X higher respectively).  These assays were performed using a reverse transcription of mRNA isolated by biopsy from colonoscopy tissue samples, using a PCR format with specific primers.  The levels of methylation were analyzed by a bisulfite genomic sequencing method.  For more information about these techniques, please see the references below.

 

  • H. Cui, M. Cruz-Correa, F. M. Giardiello, D. F. Hutcheon, D. R. Kafonek, S. Brandenburg, Y. Wu, X. He, N. R. Powe, and A. P. Feinberg, Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk Science 299 (2003) 1753-55.

  • H. Uejima, M. P. Lee, H. Cui, and A. P. Feinberg, Nature Genet. 25, 375-376 (2000).

  • Feinberg, AP: Genomic imprinting and cancer. In The Metabolic and Molecular Bases of Inherited Disease, 8th ed. Scriver CR, Beaudet AR, Sly W, Valle D (eds), McGraw-Hill, New York, pp 525-537, 2001.

Hydrophobic Stains for 2D-SDS-PAGE.

The ability to stain proteins inside SDS-PAGE gels offers a significant advantage over chemical labeling techniques or blotting / post-electrophoresis staining and destaining methods.  John Shultz and Gregg Larson (Promega Corp., Madison, WI) recently introduced a number of hydrophobic analogs of fluorescent dyes (fluorescein, Dansyl chloride, carbocyanines, etc.) that can be used for direct and quantitative labeling of proteins inside polyacrylamide gels.  The stains bind to the SDS hydrophobic protein coat and exhibit low background fluorescence.  For more information about these stains and techniques, please see the references below.

  • Larson, Gregg A.; Shultz, John W., Applications Of The Chromaphor Protein Recovery System. BioTechniques, 15:316-323.

  • Shultz, John W., Larson, Gregg A.., Protein Staining Compositions and Methods, US Patent 5,705,649 (1998).

  • Kendrick, N., Laser scanning quantification of 2-D gel spots using ChromaPhorTM Green Stain, Promega Notes Magazine 37 (1992) 11.

 

AHAS Reporter Gene in Plants.

Acetohydroxyacid synthase (AHAS, EC 4.1.3.18) also known as acetolactate synthase, is an herbicide-resistance selection marker used in plant cell studies.  It catalyzes the first step in branched-chain amino-acid (valine, leucine and isoleucine) biosynthesis, and when a modified version is cloned into plants, detoxifies the inhibition of the enzyme by sulfonylurea herbicides slufometuron methyl and chlorosuluron (marketed by Du Pont as the active ingredients in Oust and Glean, respectively) and the inidazolinone herbicides 2-(4-isopropyl-4-methyl-5-oxo-2-inidazolin-2-yl)-nicotinic acid and 2-(4-isopropyl-4-methyl-5-oxo-2-inidazolin-2-yl)-3-quinolinecarboxylic acid (marketed by American Cyanamid as the active ingredients in Arsenal and Scepter, respectively).  The recombinant plants carry a mutation (changing the serine (coded by AGT) at position 621 to asparagine (AAT), which provides a relief of the inhibition by these herbicides.  An assay of this AHAS reporter has been developed, involving conversion of the enzymatic product acetolactate to acetoin, followed by detection as a complex with creatine and naphthol.  For more information about this selection marker gene in plants see the references below.

  • Singh, B.K., Stidham, M.A., Shaner, D.L., Assay of Acetohydroxyacid Synthase Anal. Biochem.  171 (1988) 173-179.

  • Hill, C.M., Pang, S.S., Duggleby, R.G., Purification of E.Coli acetohydroxyacid synthase isoenzyme II and reconstitution of active enzyme from its individual pure subunits. Biochem. J. 327 (1997) 891-898.

  • Schloss, J.V., Van Dyk, D.E., Vasta,. J.F., Kutny, R.M., Purification and Properties of Salmonella typhimurium Acetolactate Synthase Isozyme II from E. Coli HB101/pDU9, Biochemistry 24 (1985) 4952-4959.

  • Zhu T, Peterson DJ, Tagliani L, St. Clair G, Baszczynski CL, and Bowen B. 1999. Targeted manipulation of maize genes in vivo using chimeric RNA/DNA oligonucleotides. Proceedings of the National Academy of Science 96:8768-8773.

  • Zhu T, Mettenburg K, Peterson DJ, Tagliani L, and Baszczynski CL. 2000. Engineering herbicide-resistant maize using chimeric RNA/DNA oligonucleotides. Nature Biotechnology 18:555-558.

 

Bacterial Detection using FDG

Fluorescein di-b-D-Galactopyranoside (FDG, M0250) is a popular substrate for measuring cloned beta-Galactosidase activity in living cells.  It has also found utility in staining and quantifying bacteria, as well as in isolating specific strains of bacteria by fluorescence activated cell-sorting (FACS) analysis.  Interestingly, FDG was found to be about 70 times more sensitive in bacterial  assays than GFP.  For more information about FDG staining of bacteria, see the references below:

  • b-Galactosidase Activity in Single Differentiating Bacterial Cells." F. Russo-Marie, Roederer, M. Sager, B., Herzenberg, L., Proc. Natl. Acad. Sci. USA 90:8194 (1993).

  • Nelis, H.; Van Poucke, S. Enzymatic detection of coliforms and Escherichia coli within 4 hours." Water, Air, and Soil Pollution (2000), 123(1-4): 43-52.

  • Dreier, Jurg; Breitmaier, Eva B.; Gocke, Elmar; Apfel, Christian M.; Page, Malcolm G. P. Direct influence of S9 liver homogenate on fluorescence signals: impact on practical applications in a bacterial genotoxicity assay." Mutation Research (2002), 513(1-2): 169-182.

  • Rowland B ; Purkayastha A ; Monserrat C ; Casart Y ; Takiff H ; McDonough KA (1999) Fluorescence-based detection of lacZ reporter gene expression in intact and viable bacteria including Mycobacterium species FEMS Microbiol. Lett. 179(2): 317-25

 

Whole body Luciferase detection in vivo.

Dr. Christopher Contags group at Stanford Medical School, along with collaborators at Xenogen Corp. have recently demonstrated the ability to measure light emission from transfected firefly luciferase activity inside living tissues and in vivo by injecting live animals with D-luciferin (M0237).  The ability to measure tumor growth and tumor burden in vivo as well as the possibility to streamline development of many types of therapies, including DNA-based gene therapies and gene vaccines, are exciting.  For more information about whole body luciferase gene analysis, see the references below:

  • Christopher H. Contag, Stanley D. Spilman, Pamela R. Contag, Masafumi Oshiro, Brian Eames, Phyllis Dennery, David K. Stevenson, David A. Benaron Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter Photochemistry and Photobiology (1997) 66(4): 523-531.

  • Pamela R. Contag, I. Nick Olomu, David K. Stevenson and Christopher H. Contag, Bioluminescent Indicators in Living Mammals Nature Medicine, New Technology Section (1998) 4(2):245-247.

 

Protein traffic using caged-GFP.

The movement of proteins inside the cell is an important area of study for understanding their function and interactions with intracellular organelles.  Dr. Jennifer Lipppincott-Schwartzs lab at NIHs Cell Biology and Metabolism Branch (NICHD) is studying the trafficking kinetics of proteins traversing the secretory and endocytic pathways and how they are affected by different pharmacological and physiological conditions using some newly developed caged-GFP protein tools.  A new GFP, called PA-GFP (for photo-activatable green fluorescent protein) has been modified at position 203 with a histidine substitution.  This PA-GFP can be activated by a short pulse of light at 413nm and used to follow the distribution of PA-GFP fusion proteins inside the cell in a temporal fashion.  For more information about these cell monitoring techniques, see the references below:

  • Hirschberg, K., Miller, C.M, Presley, J.F., Ellenberg, J., Zaal, K., Cole, N.B., Siggia, E., Phair, and Lippincott-Schwartz, J. (1998) Kinetic and morphological analysis of secretory protein traffic in living cells. J. Cell Biol. 143: 1485-1503.

  • Patterson, G.H., Lippincott-Schwartz, J., (2002) A Photoactivatable GFP for Selective Photolabeling of Proteins and Cells. Science 297(5588): 1873-1876.

Human Antibody Production in Plants. 

Transgenic plants have been engineered by researchers from the Scripps Research Institute and Epicyte Pharmaceuticals (San Diego, CA) to produce recombinant human monoclonal antibodies.  These plant-based systems can provide significant cost advantages over traditional mammalian cell culture systems.  In addition, the unwanted effects of immune-sensitive glycosylation patterns are reduced from expression in plant systems.  Among the antibodies currently under production are those for HSV, HIV, pneumonia (respiratory syncytial virus) and intestinal infection (clostridium difficile).  For more information about these plant expression systems, see the references below:

  • Zeitlin L, Olmsted S, et al. (1998). "A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes" Nature Biotechnology16:1361-1364:

  • Ma JK-C, Lehner T, Stabila P, Fux C, Hiatt AC (1994). "Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants" Euro. Jr. Immunol. 24: 131-138.

  • Ma, JK-C, Hiatt AC, Hein MB, Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K, Lehner T (1995). "Generation and assembly of secretory antibodies in plants" Science 268: 716-719.

Lipase Activity measured in Live Cells.

Triacylglycerides are metabolized inside living cells by lipases [EC 3.1.1.3].  In normal serum the concentration of lipase is low. In acute pancreatitis and in pancreatic carcinoma a rise in serum lipase activity occurs, with a mean increase being about 50 times that of normal values. A rise in the serum lipase content is also found in acute and chronic renal diseases.  Sensitive measurement of lipase activity in live cells can be accomplished using the fluorescent substrate 1,2-Dioleoyl-3-(pyren-1-yl)decanoyl-rac Glycerol (M0258).  Upon enzymatic cleavage, the fluorescent fatty acid, pyrenedecanoic acid (M0274) is released, which accumulates in cellular membranes.  Upon eximer formation, the fluorescence of this product shifts to longer wavelength, and can be distinguished from that of the substrate, because it forms eximers inside the membrane (EM: 470nm @ EX: 390nm).  This assay is quantitative and can be used with mammalian or bacterial cell lines.  For more information about this assay see the references below:  NOTE: Marker Gene also sells a convenient Fluorescent Lipase Assay Kit (M0612) with all of the reagents and a detailed protocol for measuring lipase activity in living cells.

  • Dousset, N., Negre, A., Salvayre, R., Rogalle, P., Dang, Q.Q., Douste-Blazy, L. (1988). Use of a fluorescent radiolabeled triacylglycerol as a substrate for lipoprotein lipase and hepatic triglyceride lipase. Lipids 23: 605-608.

  • Main, L.A., Okumura-Noji, K., Ohnishi, T., Yokoyama, S., (1998) Cholesteryl ester transfer protein reaction between plasma lipoproteins. J. Biochem. (Tokyo) 124: 237-243.

 

Jet-Lag and Circadian Rhythms in Plants.

The effects of daylight length and time-changes, and the physiological events that occur in eukaryotic cells in response to these events, have long intrigued scientists.  Some of these processes are beginning to be understood in plants and animals by cloning marker genes (for example firefly luciferase, luc) into cells under control of specific circadian promoter elements.  By adding the reagent D-luciferin (M0237) to these cloned tissues, Steven Kays lab at the Scripps Research Institute in San Diego (see: http://www.scripps.edu/cb/kay/) has identified several new genes that light up, i.e. are responsible for the physiological changes in plants and animals, when daylight and night-time cycled gene expression occurs.  For more information, see the references below:

  • Covington, M.F., Panda, S., Liu, X.L., Strayer, C.A., Kay, S.A., Wagner, D.R. (2001) ELF3 modulates resetting of the circadian clock in Arabidopsis. The Plant Cell 13, 1305-1316.

  • Millar A.J. and Kay S.A. (1996). Integration of circadian and phototransduction pathways in the network controlling CAB gene transcription in Arabidopsis. Proc. Natl. Acad. Sci. USA, 93, 15491-15496.

  • Millar A.J., Straume M., Chory J., Chua N.-H. and Kay S.A. (1995) The regulation of circadian period by phototransduction pathways in Arabidopsis. Science, 267, 1163-1166.

 

FDG Staining of live Zebrafish Embryos

Over the last several years, the zebrafish has emerged as an attractive model for vertebrate developmental biology, largely because of the ease of genetic analysis and the transparent nature of the embryo.  However, despite many advantages, zebrafish researchers still require certain experimental tools, including viable embryonic markers for genetic and cell lineage studies.  Staining with the fluorescent b-galactosidase substrate FDG (M0250) is a popular method of detecting transgenic activity in these embryos when using the lacZ reporter gene, but may require dechorionation of the embryos prior to staining. 

See the references below for more information about these techniques.

  • Rossant, J., Hopkins, N. (1992) Of fin and fur: mutational analysis of vertebrate embryonic development.

  • Genes Devel. 6:113.Lin S, Yang S, Hopkins N. lacZ expression in germline transgenic zebrafish can be detected in living embryos. Dev. Biol. (1994) 161(1):77-83

 

Oxidative Burst in Neutrophils with DHR123

The reduced or missing oxidative burst activity in leukocytes is an indication of hereditary diseases like chronic granulomatous disease (CGD).  Treatment of cells (e.g. heparinized whole blood) with the reduced dye DHR123, (dihydrorhodamine 123, M0545) is a sensitive assay for oxidative activity in such cells, with allied induction using either the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP), the protein kinase C ligand phorbol 12-myristate-13-acetate (PMA) or bacterial challenge.  DHR123 is practically non-fluorescent until oxidized intracellularly to the bright red fluorescent rhodamine 123 product.  For more information see the references listed below or visit our Website:

  • Rothe G, Oser A & G. Valet. (1988) Dihydrorhodamin 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 75: 354 - 355.

  • Dobmeyer, T.S., Raffel, B. Dobmeyer, J.M., Findhammer, S., Klein, S.A., Kabelitz, D. Hoelzer, D., Helm, E.B. & Rossol.(1995) Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur. J. Med. Res. 1: 9-15.

  • Gessler, P., Nebe, T. Birle, A., Haas, N. & W. Kachel. (1996) Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-Reactive Protein. Pediatr. Res. 39: 843-848.

  • Elbim, C., Chollet-Martin, S., Bailly, S., Hakim, J. & M.A. Gougerot-Pocidalo. (1993) Priming of polymorphonuclear neutrophils by tumor necrosis factor in whole blood: Identification of two polymorphonuclear neutrophil subpopulations in response to formyl-peptides. Blood 82: 663-640.

 

 Adoptive Immunotherapy for Melanomas

 

Steven Rosenbergs laboratory at the National Cancer Institute recently reported results of a new study were reactive killer T-cells were removed from patients tumor regions, and grown in culture to high density.  When re-infused into these same patients, their ability to mount an immune response to the tumors was highly improved.  The key factors of cell viability (and proliferation) during culturing and after re-infusion were addressed using a regimen where the patients own immune system was depleted before transfer (prior lymphodepletion using a combination of drugs).  These techniques present a potential promising new weapon for the treatment of cancer using the bodys own immune system. 

 

  • Dudley et al. (2002) Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes. Science 298 (5594): 850-854.

  • Winter, H., Fox, B.A., Adoptive Cellular Immunotherapy of Cancer. Current Opinion in Molecular Therapeutics. 1 (1):89-97,1999. 

Black Spot Disease in Citrus Fruits

Black Spot is a fungal disease caused by Guignardia citricarpa. It causes black lesions on citrus fruits like oranges and grapefruits, and is becoming a threat to the US agriculture industry.  The disease has not been reported in U.S. citrus producing states, but has been found in parts of Australia, South Africa and Argentina and is becoming a serious problem in Brazil.  Importation or export of fruits from the US are in jeopardy since the European Union (EU) and South Africa in 2000 now threaten to slow citrus exports because of zealous application of protective standards.  Recently several assays including a definitive PCR-based assay have been developed, which may alleviate these quarantine issues.  For more information on the disease and these assays, see the references below:

  • Baayen, R.P. , (2002) Nopathogenic isolates of the citrus black spot fungus, Guignardia citricarpa, identified as a cosmopolitan endophyte of woody plants, G. mangiferae (Phyllosticta capitalensis), Phytopathology 92 (5): 464-477.

 

MGT-M0114 2',7'-bis(Carboxyethyl)-5(6) carboxyfluorescein [BCECF]
MGT-M0637 2-Chloro-4-nitrophenyl-b-D-cellobioside
MGT-M0553 2-Chloro-4-nitrophenyl-b-D-lactoside
MGT-M0241 4-Methylumbelliferyl b-D-galactopyranoside [MUGal]
MGT-M0240 4-Methylumbelliferyl b-D-glucuronide [MUGlcU]
MGT-M0554 4-Methylumbelliferyl-b-D-lactoside
MGT-M0252 4-Trifluoromethylumbelliferyl-b-D galactopyranoside [TFMU-Gal]
MGT-M0122 5(6)-Carboxyfluorescein
MGT-M0276 b-Galactosidase Sample Kit
MGT-M0272 Carbohydrate Analysis/Detection Kit
MGT-M0011 Carboxyfluorescein di-O-acetate [CFDA]
MGT-M0013 Carboxyfluorescein di-O-acetate, NHS ester
MGT-M0257 Carboxyumbelliferyl b-D-galactopyranoside [CUGal]
MGT-M0256 Carboxyumbelliferyl b-D-glucuronide [CUGlcU]
MGT-M0520 Cyclic adipoyl-(6-amino)hexanoyl-DEVD-rhodamine 110 . TEA salt
MGT-M0147 Cycloheximide 2-O-b-D-galactopyranoside
MGT-M0149 Dexamethasone 21-O-b-D-galactopyranoside
MGT-M0545 Dihydrorhodamine 123 [DHR123]
MGT-M0583 Etoposide 4-O-b-D-galactopyranoside
MGT-M0255 FACS lacZ b-Galactosidase Detection Kit
MGT-M0250 Fluorescein di-b-D-galactopyranside [FDG]
MGT-M0308 Fluorescein di-b-D-N-acetylgalactoside
MGT-M0060 Fluorescein di-O-acetate [FDA]
MGT-M0064 Fluorescein mono-b-D-galactoside [FMGal]
MGT-M0065 Fluorescein mono-b-D-glucoside [FMGlc]
MGT-M0204 Fluorescein, high purity standard
MGT-M0612 Fluorescent Lipase Assay Kit
MGT-M0259 In vivo lacZ b-Galactosidase Intracellular Detection Kit
MGT-M0626 Luciferase Assay Kit
MGT-M0237 Luciferin
MGT-M0271 Membrane Fluidity Kit
MGT-M0260 Phenethylthio-b-glucoside [PETG]
MGT-M0261 Phenethylthio-b-glucuronide [PETGU]
MGT-M0215 Phorbol 12-O-octanoyl-13-O-acetyl-6-O-b-D-galactopyranoside
MGT-M0203 Resorufin b-D-galactopyranoside [Res-Gal]
MGT-M0202 Resorufin, high purity standard
MGT-M0041 Trifluoromethylumbelliferone [TFMU]

 

 

 



Vinci-Biochem Cataloghi e Letteratura   Cerca Prodotti About us

 
Per ordini, richiedere preventivi o informazioni / For ordering, request quotations or information:

Vinci-Biochem - Via Ponte di Bagnolo, 10
50059 Vinci (Firenze)
Italia
Tel. +39 0571 568 147
Fax +39 0571 568 132
vb@vincibiochem.it

 

PRODOTTI ESCLUSIVAMENTE PER RICERCA, NON PER USO SULL'UOMO, NON PER USO DIAGNOSTICO SE NON DIVERSAMENTE SPECIFICATO

ALL OUR PRODUCTS ARE FOR RESEARCH USE ONLY, IF NOT OTHERWISE SPECIFIED

 

Copyright ©2011 Vinci-Biochem